BiomX Inc.

NYSEAM:PHGE.U Stock Report

Market Cap: US$15.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

BiomX Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jonathan Solomon

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage36.8%
CEO tenure5yrs
CEO ownership0.3%
Management average tenure5yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jonathan Solomon's remuneration changed compared to BiomX's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$26m

Mar 31 2024n/an/a

-US$34m

Dec 31 2023US$1mUS$412k

-US$26m

Sep 30 2023n/an/a

-US$27m

Jun 30 2023n/an/a

-US$25m

Mar 31 2023n/an/a

-US$27m

Dec 31 2022US$1mUS$425k

-US$28m

Sep 30 2022n/an/a

-US$33m

Jun 30 2022n/an/a

-US$36m

Mar 31 2022n/an/a

-US$36m

Dec 31 2021US$1mUS$391k

-US$36m

Sep 30 2021n/an/a

-US$35m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$1mUS$339k

-US$30m

Sep 30 2020n/an/a

-US$27m

Jun 30 2020n/an/a

-US$23m

Mar 31 2020n/an/a

-US$22m

Dec 31 2019US$937kUS$286k

-US$21m

Sep 30 2019n/an/a

-US$22m

Jun 30 2019n/an/a

-US$19m

Mar 31 2019n/an/a

-US$17m

Dec 31 2018US$605kUS$276k

-US$15m

Dec 31 2017US$566kUS$266k

-US$7m

Compensation vs Market: Jonathan's total compensation ($USD1.12M) is above average for companies of similar size in the US market ($USD655.02K).

Compensation vs Earnings: Jonathan's compensation has increased whilst the company is unprofitable.

CEO

Jonathan Solomon (47 yo)

5yrs

Tenure

US$1,118,541

Compensation

Mr. Jonathan Eitan Solomon, MBA, serves as Chief Executive Officer and Director of BiomX Inc. since October 2019. He served as Chief Executive Officer of BiomX Ltd since February 2017 until October 2019 a...

Leadership Team

NamePositionTenureCompensationOwnership
Jonathan Solomon
CEO & Director5yrsUS$1.12m0.30%
$ 46.7k
Marina Wolfson
CFO & Secretary4.8yrsUS$428.26k0.0021%
$ 330.7
Merav Bassan
Chief Development Officer5yrsUS$590.93k0.18%
$ 27.9k
Rotem Sorek
Scientific Founderno datano datano data
Eran Elinav
Scientific Founderno datano datano data
Timothy Lu
Scientific Founderno datano datano data
Inbal Benjamini-Elran
C.H.R.O4.8yrsno datano data
Assaf Oron
Chief Business Officer5yrsUS$496.21k0.14%
$ 22.7k

5.0yrs

Average Tenure

47yo

Average Age

Experienced Management: PHGE.U's management team is seasoned and experienced (5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jonathan Solomon
CEO & Director5yrsUS$1.12m0.30%
$ 46.7k
Jonathan Leff
Independent Directorless than a yearno datano data
Gregory Merril
Independent Directorless than a yearno datano data
Russell Greig
Independent Chairman of the Board5yrsUS$161.58k0.0021%
$ 330.7
Alan Moses
Independent Director4yrsUS$81.43k0.0028%
$ 439.3
Edward Williams
Independent Directorless than a yearUS$8.79kno data
Jesse Goodman
Independent Directorless than a yearno datano data
Susan Blum
Independent Directorless than a yearno datano data

0.8yrs

Average Tenure

63yo

Average Age

Experienced Board: PHGE.U's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/27 09:56
End of Day Share Price 2024/10/25 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BiomX Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristen KluskaCantor Fitzgerald & Co.
Joseph PantginisH.C. Wainwright & Co.
I-Eh JenLaidlaw & Company (UK) Ltd